Edamadaka Yeshwanth, Parghane Rahul V, Basu Sandip
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, Maharashtra, India.
Homi Bhabha National Institute, Mumbai, Maharashtra, India.
World J Nucl Med. 2024 Oct 25;24(1):93-95. doi: 10.1055/s-0044-1792029. eCollection 2025 Mar.
Radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC) have poor prognosis as compared with radioiodine concentrating thyroid carcinoma. We present a case of follicular thyroid carcinoma presenting as a disseminated disease initially, underwent thyroid surgery and radioiodine (RAI) therapy. Following RAI, the patient developed a sudden-onset unilateral proptosis, finally diagnosed as orbital metastasis. [ F]-Fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography identified FDG-avid metastatic lesions more numerous than the RAI-avid lesions. The patient was treated with local and systemic targeted therapy, but despite these treatments, he developed progressive disease indicating aggressive nature of the disease consistent with [ F]FDG-avid RAIR-DTC.
与摄取放射性碘的甲状腺癌相比,放射性碘难治性分化型甲状腺癌(RAIR-DTC)的预后较差。我们报告1例最初表现为播散性疾病的滤泡状甲状腺癌患者,该患者接受了甲状腺手术及放射性碘(RAI)治疗。RAI治疗后,患者突然出现单侧眼球突出,最终诊断为眼眶转移。[¹⁸F]氟脱氧葡萄糖(FDG)正电子发射断层扫描计算机断层扫描显示,FDG摄取阳性的转移灶比RAI摄取阳性的病灶更多。该患者接受了局部和全身靶向治疗,但尽管进行了这些治疗,他仍出现疾病进展,这表明该疾病具有侵袭性,与[¹⁸F]FDG摄取阳性的RAIR-DTC一致。